Related Experiment Video
Updated: Jul 18, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Idiopathic membranous nephropathy and synchronous mononeuritis multiplex secondary to idiopathic small vessel
Kalpa Jayanatha1,2, Ashutosh Kumar2, Mark Sapsford3
1Medicine, The University of Auckland, Auckland, New Zealand kalpa.jayanatha@auckland.ac.nz.
Abstract:
Membranous nephropathy has been associated with demyelinating polyneuropathies and antiglomerular membrane disease; however, an association with vasculitic neuropathy has not been described. This case describes a patient with biopsy-proven idiopathic membranous nephropathy and synchronous mononeuritis multiplex secondary to idiopathic small vessel vasculitis, who presented with lower limb microvascular ischaemia, peripheral neuropathy and active urinary sediment. Her extensive non-invasive screening for immunological disease and radiological investigations for occult malignancy were unremarkable. The patient received intravenous methylprednisolone and intravenous rituximab induction therapy resulting in complete remission of both the idiopathic membranous nephropathy and small vessel vasculitis at 7 months post treatment.
Insights
This study details a rare case of idiopathic membranous nephropathy occurring simultaneously with small vessel vasculitis, presenting as neuropathy. Effective treatment with rituximab and methylprednisolone led to remission of both conditions.
Area of Science:
- Nephrology
- Neurology
- Immunology
Background:
- Membranous nephropathy is typically linked with demyelinating polyneuropathies.
- An association between membranous nephropathy and vasculitic neuropathy is not well-documented.
Observation:
- A patient presented with biopsy-proven idiopathic membranous nephropathy.
- The patient also had synchronous mononeuritis multiplex due to idiopathic small vessel vasculitis.
- Symptoms included lower limb microvascular ischemia, peripheral neuropathy, and active urinary sediment.
Findings:
- Extensive screening ruled out other immunological diseases and occult malignancy.
- The patient received intravenous methylprednisolone and rituximab induction therapy.
- Complete remission of both idiopathic membranous nephropathy and small vessel vasculitis was achieved at 7 months.
Implications:
- This case highlights a potential, previously undescribed association between membranous nephropathy and vasculitic neuropathy.
- It underscores the importance of considering vasculitis in patients with membranous nephropathy and neurological symptoms.
- Successful treatment with rituximab and corticosteroids suggests a viable therapeutic strategy for this combined condition.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
Nephrotic Syndrome I : Introduction
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction